Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Amneal Plans Eight More ‘High Value’ Launches
Company Awaits FDA Approval For 91 Products
Aug 13 2020
•
By
Akriti Seth
Amneal says it will meet its targets despite COVID-19 related headwinds • Source: Shutterstock
More from Earnings
More from Business